$2.38, thank you. Too many retail investors listening to AFR/PWC on things they should have already known. Expect far less cash burn with trials having been completed and now onto some nice partnerships and well funded trials.
This is a specialist orthopedic fund who clearly recognises the science, mechanisms of treatment and huge potential of MSB. I was only explaining their CLBP trials/results to a mate with DDD and a good understanding of the pathology and he was mesmerized as no doubt many informed investors like these guys are by the prospects.
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group, page-77
-
- There are more pages in this discussion • 432 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.50 |
Change
0.010(0.67%) |
Mkt cap ! $1.689B | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.58 | $1.41 | $11.43M | 7.652M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 30936 | $1.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.50 | 2025 | 2 |
View Market Depth
| Last trade - 12.24pm 07/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |